Researchers have published initial results from a clinical trial using focused ultrasound neuromodulation for the treatment of opioid use disorder.
The intervention significantly reduced substance cravings, and most participants did not use opioids or other substances during the 90-day follow-up period.
Philip Bergman, DVM, MS, PhD, DACVIM-Oncology, will serve as a consultant to the veterinary and the cancer immunotherapy programs.
He was director of clinical studies for VCA Animal Hospitals and Mars Veterinary Hospital and is the principal veterinary investigator for the canine melanoma vaccine.
“The Foundation has been pivotal in helping to establish cross collaborations with major veterinary practice networks. I am deeply grateful for the Foundation’s invaluable contributions to this field.”
‒ Ashish Ranjan, BVSc, PhD
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.